Sage Journals: Discover world-class research

Abstract

Analysis of human genetic data promises to uncover important disease targets. Genes known to cause or increase susceptibility for various diseases are being identified through analysis of genetic data, expression and metabolites. Future benefits to individuals are far-reaching, including improved gene therapy strategies, better drug development for disease treatment, pre-symptomatic disease intervention and risk susceptibility information. The rapid expansion of genetic databases has resulted in the emerging areas of genomics, transcriptomics, proteomics and metabolomics. The article presents a comprehensive overview of Internet databases, their trends over time and what 'omics' type they embody. With the completion of the human genome we are entering the postgenomic era. The use of microarrays and database software for genomic, transcriptomic, proteomic and metabolomic data for clinical assays and new diagnostic therapeutics will result in large, interlinked databases that will present unique issues of data management, standardization and information sharing.

Keywords

bioinformatics genomics metabolomics proteomics public databases transcriptomics

References

Maxam A M , Gilbert W. A new method for sequencing DNA . Proceedings of the National Academy of Sciences USA 1977; 74 (2); 560-564 .

Sanger F , Nicklen S , Coulson A R. DNA sequencing with chain-terminating inhibitors . Biotechnology 1992; 24; 104-108 .

Mullis K , Faloona F , Scharf S , Saiki R , Horn G , Erlich H. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction . Cold Spring Harbour Symposia on Quantitative Biology 1986; 51 (1); 263-273 .

Fleischmann R D , Adams M D. Whole-genome sequencing and assembly of Haemophilus influenzae Rd . Science 1995; 269; 496-512 .

Adams M D , et al. The genome sequence of Drosophila melanogaster . Science 2000; 287 (5461); 2185-2195 .

Waterson R H , et al. Initial sequencing and comparative analysis of the mouse genome . Nature 2002; 420 (6915); 520-562 .

Ventner J C , et al. The sequence of the human genome . Science 2001; 291 (5507); 1304-1351 .

Boguski M S. Bioinformatics . Current Opinion in Genetics & Development 1994; 4 (3); 383-388 .

McKusick V A. Genomics: structural and functional studies of genomes . Genomics 1997; 45 (2); 244-249 .

10.

Baxevanis A D. The Molecular Biology Database Collection: 2003 update . Nucleic Acids Research 2003; 31 (1); 1-12 .

11.

Galperin M Y. The Molecular Biology Database Collection: 2004 update . Nucleic Acids Research 2004; 32; D3-D22 .

12.

Waterfall C M , Cobb B D. Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis . Nucleic Acids Research 2001; 29 (23); E119 .

13.

Ma M K , Woo M H , McLeod H L. Genetic basis of drug metabolism . American Journal of Health System Pharmacy 2002; 59 (21); 2061-2069 .

14.

Koch H G , McClay J , Loh E W , Higuchi S , Zhao J H , Sham P , Ball D , Craig I W. Allele association studies with SSR and SNP markers at known physical distances within a 1 Mb region embracing the ALDH2 locus in the Japanese, demonstrates linkage disequilibrium extending up to 400 kb . Human Molecular Genetics 2000; 9 (20); 2993-2999 .

15.

Jick H. Adverse drug reactions: the magnitude of the problem . Journal of Allergy & Clinical Immunology 1984; 74; 555-557 .

16.

Rooney P H , Telfer C , McFadyen M C , Melvin W T , Murray G I. The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions . Current Cancer Drug Targets 2004; 4 (3); 257-265 .

17.

Hersch S M. Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation . Current Opinion in Neurology 2003; 16 (4); 501-506 .

18.

Brewer G J. Zinc acetate for the treatment of Wilson's disease . Expert Opinion in Pharmacotherapy 2001; 2 (9); 1473-1477 .

19.

Grant G M , Fortney A , Gorreta F , Estep M , Del Giacco L , Van Meter A , Christensen A , Appalla L , Naouar C , Jamison C , Al-Timimi A , Donovan J , Cooper J , Garrett C , Chandhoke V. Microarrays in cancer research . Anticancer Research 2004; 24 (2A); 441-448 .

20.

Scherf U , Ross D T , Waltham M , Smith L H , Lee J K , Tanabe L , Kohn K W , Reinhold W C , Myers T G , Andrews D T , Scudiero D A , Eisen M B , Sausville E A , Pommier Y , Botstein D , Brown P O , Weinstein J N. A gene expression database for the molecular pharmacology of cancer . Nature Genetics 2000; 24 (3); 236-244 .

21.

Xiang C C , Chen Y. cDNA microarray technology and its applications . Biotechnology Advances 2000; 18 (1); 35-46 .

22.

Yanagisawa K , Shyr Y , Xu B J , Massion P P , Larsen P H , White B C , Roberts J R , Edgerton M , Gonzalez A , Nadaf S , Moore J H , Caprioli R M , Carbone D P. Proteomic patterns of tumour subsets in non-small-cell lung cancer . Lancet 2003; 362 (9382); 433-439 .

23.

Chambers G , Lawrie L , Cash P , Murray G I. Proteomics: a new approach to the study of disease . Journal of Pathology 2000; 192 (3); 280-288 .

24.

Watkins S M , German J B. Metabolomics and biochemical profiling in drug discovery and development . Current Opinion in Molecular Therapeutics 2002; 4 (3); 224-228 .

25.

Wang Z , Wang G. APD: the Antimicrobial Peptide Database . Nucleic Acids Research 2004; 32; D590-D592 .

26.

Danzon P , Towse A. The economics of gene therapy and of pharmacogenetics . Value Health 2002; 5 (1); 5-13 .

27.

Gardiner-Garden M , Littlejohn T G. A comparison of microarray databases . Brief Bioinformatics 2001; 2 (2); 143-158 .

28.

Murphy D. Gene expression studies using microarrays: principles, problems and prospects . Advances in Physiology Education 2002; 26; 256-270 .

29.

Mattes W B , Pettit S D , Sansone S A , Bushel P R , Waters M D. Database development in toxicogenomics: issues and efforts . Environmental Health Perspectives 2004; 112 (4); 495-505 .

30.

Orchard S , Taylor C , Hermjakob H , Zhu W , Julian R , Apweiler R. Current status of proteomic standards development . Expert Review of Proteomics 2004; 1 (2); 179-183 .

31.

Tong W , Harris S , Cao X , Fang H , Shi L , Sun H , Fuscoe J , Harris A , Hong H , Xie Q , Perkins R , Casciano D. Development of public toxicogenomics software for microarray data management and analysis . Mutation Research 2004; 549 (1-2); 241-253 .

32.

Anderle P , Duval M , Draghici S , Kuklin A , Littlejohn T G , Medrano J F , Vilanova D , Roberts M A. Gene expression databases and data mining . Biotechniques 2003 (Mar Suppl); 36-44 .

33.

Becker K G The sharing of cDNA microarray data . Nature Reviews Neuroscience 2001; 2 (6); 438-440 .

34.

Thomas S M. Genomics: the implications for ethics and education . British Medical Bulletin 1999; 55 (2); 429-445 .

35.

Fedder R S. To know or not to know: legal perspectives on genetic privacy and disclosure of an individual's genetic profile . Journal of Legal Medicine 2002; 21 (4); 557-592 .

36.

Gerard S , Hayes M , Rothstein M A. On the edge of tomorrow: fitting genomics into public health policy . Journal of Law, Medicine & Ethics 2002; 30 (3 Suppl): 173-176 .

Current trends in publicly available genetic databases

Abstract

Keywords

References